GlassScriptPhysician profile
Stephen J Talley
NPI 1770581852
$1,083.36
in general payments reported to CMS, 2019-2025
13 companies · $695 in 2025
The $695 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.64 · 2021: $138 · 2022: $11.77 · 2023: $51.60 · 2024: $175 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $372.02 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $212.50 | 2024-2025 | Dupixent |
| Glaxosmithkline, LLC. | $128.14 | 2024-2025 | Nucala |
| Medtronic, INC. | $112.02 | 2025 | Propel |
| Neurent Medical Limited | $73.54 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Ars Pharmaceuticals Operations, INC. | $46.76 | 2025 | Neffy |
| Fisher & Paykel Healthcare INC | $34.90 | 2023 | Fisher & Paykel Healthcare |
| Paratek Pharmaceuticals, INC. | $23.95 | 2025 | Xhance |
| Inspire Medical Systems, INC. | $22.86 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $16.29 | 2021 | |
| Alk-Abello, INC | $14.90 | 2025 | Odactra, Ragwitek, Grastek |
| Lucid Diagnostics INC. | $13.84 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Talley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.